Evaluation of various compounds to inhibit activity of matrix metalloproteinases in the tear film of horses with ulcerative keratitis

American Journal of Veterinary Research

Volumn 64, Issue 9, 2003, Pages 1081-1087

  Ollivier, Franck J ^a   Brooks, Dennis E ^a   Kallberg, Maria E ^a   Komaromy, Andras M ^a   Lassaline, Mary E ^a   Andrew, Stacy E ^c   Gelatt, Kirk N ^a   Stevens, Gary R ^b   Blalock, Timothy D ^a   van Setten, Gysbert Botho ^d   Schultz, Gregory S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b University of Florida College of Veterinary Medicine   (United States)

^c NONE   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA 1 ANTITRYPSIN; DIPEPTIDE; DOXYCYCLINE; EDETIC ACID; GELATINASE A; GELATINASE B; HYDROXAMIC ACID; ILOMOSTAT; MATRIX METALLOPROTEINASE INHIBITOR; PROTEINASE INHIBITOR; TETRACYCLINE; UNCLASSIFIED DRUG;

CONTROLLED STUDY; CORNEA ULCER; ENZYME ACTIVITY; ENZYME INHIBITION; HORSE; IN VITRO STUDY; NONHUMAN; OPTICAL DENSITY; REVIEW; SAMPLE; SEDATION; TEAR FILM; ZYMOGRAPHY;

ACETYLCYSTEINE; ALPHA 1-ANTITRYPSIN; ANIMALS; CORNEAL ULCER; DOXYCYCLINE; EDETIC ACID; ELECTROPHORESIS; HORSE DISEASES; HORSES; HYDROXAMIC ACIDS; IMAGE PROCESSING, COMPUTER-ASSISTED; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PROTEASE INHIBITORS; TEARS;

EQUIDAE; EQUUS CABALLUS;

EID: 0042280526     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2003.64.1081     Document Type: Review

References (60)

1. Brooks DE. Equine ophthalmology. In: Gelatt KN, ed. Veterinary ophthalmology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 1999;1053-1116.
2. Twining SS. Regulation of proteolytic activity in tissues. Crit Rev Biochem Mol Biol 1994;29:315-383.
3. Slansky HH, Gnadinger MC, Itoi M, et al. Collagenase in corneal ulcerations. Arch Ophthalmol 1969;82:108-111.
4. Hibbetts K, Hines B, Williams D, et al. An overview of proteinases inhibitors. J Vet Intern Med 1999;13:302-308.
5. Twining SS, Kirschner SE, Mahnke LA, et al. Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins. Invest Ophthalmol Vis Sci 1993; 34:2699-2712.
6. Matsubara M, Girard MT, Kublin CL, et al. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodeling cornea. Dev Biol 1991;147:425-439.
7. Matsubara M, Zieske JD, Fini ME. Mechanism of basement membrane dissolution preceding corneal ulceration. Invest Ophthalmol Vis Sci 1991;32:3221-3237.
8. Fini ME, Girard MT. Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea. Invest Ophthalmol Vis Sci 1990;31:1779-1788.
9. Fini ME, Cook JR, Mohan R. Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res 1998;290(suppl):S12-S23.
10. Fini ME, Girard MT, Matsubara M. Collagenolytic/gelatinolytic enzymes in corneal wound healing. Acta Ophthalmol Suppl 1992;202:26-33.
11. Azar DT, Pluznik D, Jain S, et al. Gelatinase B and A expression after laser in situ keratomileusis and photorefractive keratectomy. Arch Ophthalmol 1998;116:1206-1208.
12. Strubbe DT, Brooks DE, Schultz GS, et al. Evaluation of tear film proteinases in horses with ulcerative keratitis. Vet Ophthalmol 2000; 3:111-119.
13. Tervo T, Salonen EM, Vahen A, et al. Elevation of tear fluid plasmin in corneal disease. Acta Ophthalmol (Copenh) 1988;66:393-399.
14. Prause JU. Serum albumin, serum antiproteases and polymorphonuclear leucocyte neutral collagenolytic protease in the tear fluid of patients with corneal ulcers. Acta Ophthalmol (Copenh) 1983;61:272-282.
15. Berman M, Leary R, Gage J. Latent collagenase in the ulcerating rabbit cornea. Exp Eye Res 1977;25:435-445.
16. Berman M, Dohlman CH, Gnadinger M, et al. Characterization of collagenolytic activity in the ulcerating cornea. Exp Eye Res 1971; 11:255-257.
17. Berman MB, Manabe R. Corneal collagenases: evidence for zinc metalloenzymes. Ann Ophthalmol 1973;5:1193-1195.
18. Kernacki KA, Hobden JA, Hazlett LD, et al. In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection. Invest Ophthalmol Vis Sci 1995;36:1371-1378.
19. Ward D. Ocular pharmacology. In: Gelatt KN, ed. Veterinary ophthalmology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 1999;336-354.
20. Tervo T, van Setten GB, Tervo K, et al. Experience with plasmin inhibitors. Acta Ophthalmol Suppl 1992;202:47-53.
21. Berman M. Regulation of collagenase. Therapeutic considerations. Trans Ophthalmol Soc U K 1978;98:397-405.
22. Berman M, Gordon J, Garcia LA, et al. Corneal ulceration and the serum antiproteases. II. Complexes of corneal collagenases and alpha-macroglobulins. Exp Eye Res 1975;20:231-244.
23. Berman M. Collagenase inhibitors: rationale for their use in treating corneal ulceration. Int Ophtalmol Clin 1975;15:49-66.
24. Berman MB, Barber JC, Talamo RC, et al. Corneal ulceration and the serum antiproteases. I. Alpha 1-antitrypsin. Invest Ophthalmol Vis Sci 1973;12:759-770.
25. Whitley RD, Gilger BC. Diseases of the canine cornea and sclera. In: Gelatt KN, ed. Veterinary ophthalmology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 1999;635-671.
26. McLaughlin SA, Gilger BC, Whitley RD. Infectious keratitis in horses: evaluation and management. Compend Contin Educ Pract Vet 1992;14:372-379.
27. Severin GA. Cornea. Veterinary ophthalmology notes. 2nd ed. Fort Collins, Colo: Colorado State University Press, 1976;318-328.
28. Dursun D, Kim MC, Solomon A, et al. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids. Am J Ophthalmol 2001; 132:8-13.
29. Rawal SY, Rawal YB. Non-antimicrobial properties of tetracyclines - dental and medical implications. West Indian Med J 1984; 50:105-108.
30. Barletta JP, Angella G, Balch KC, et al. Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor. Invest Ophthalmol Vis Sci 1996;37:20-28.
31. Perry HD, Hodes LW, Seedor JA, et al. Effect of doxycycline hyclate on corneal epithelial wound healing in the rabbit alkali-burn model. Preliminary observations. Cornea 1993;12:379-382.
32. Schultz GS, Strelow S, Stern GA, et al. Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinases. Invest Ophthalmol Vis Sci 1992;33:3325-3331.
33. Golub LM, Ramamurthy N, McNamara TF, et al. Tetracyclines inhibit tissue collagenase activity. J Perdiodontal Res 1984; 19:651-655.
34. van Setten GB. Epidermal growth factor in human tear fluid: increased release but decreased concentrations during reflex tearing. Curr Eye Res 1990;9:79-83.
35. Mastumoto K. Proteases in bacterial keratitis. Cornea 2000; S19:160-164.
36. Gopinathan U, Ramakrishna T, Willcox M, et al. Enzymatic, clinical and histologic evaluation of corneal tissues in experimental fungal keratitis in rabbits. Exp Eye Res 2001;72:433-442.
37. O'Brien TP. Bacterial keratitis. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea. St Louis: Mosby Year Book Inc, 1997; 1139-1190.
38. Pfister RR, Haddox JL, Dodson RW, et al. Polymorphonuclear leukocytic inhibition by citrate, other metal chelators, and trifluoperazine. Evidence to support calcium binding protein involvement. Invest Ophthalmol Vis Sci 1984;25:955-970.
39. Pfister RR, Pfister DA. Alkali injuries of the eye. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea. St Louis: Mosby Year Book Inc, 1997;1443-1452.
40. Corbett MC, O'Bart DP, Patmore AL, et al. Effect of collagenase inhibitors on corneal haze after PRK. Exp Eye Res 2001;72:253-259.
41. Furrer P, Mayer JM, Plazonnet B, et al. Ocular tolerance of preservatives on the murine cornea. Eur J Pharm Biopharm 1999; 47:105-112.
42. Schultz GS. Modulation of corneal wound healing. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea. St Louis: Mosby Year Book Inc, 1997;183-196.
43. Smith GN Jr, Mickler EA, Hasty KA, et al. Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of the enzyme. Arthritis Rheum 1999; 42:1140-1146.
44. Seedor JA, Perry HD, McNamara TF, et al. Systemic tetracycline treatment of alkali-induced corneal ulceration in rabbit. Arch Ophthalmol 1987;105:268-271.
45. Slansky HH, Berman MB, Dohlman CH, et al. Cysteine and acetylcysteine in the prevention of corneal ulcerations. Ann Ophthalmol 1970;2:488-491.
46. Kanao S, Kouzuki S, Tsuruno M, et al. Clinical application of 3% N-acetylcysteine eye drops in corneal diseases in dogs. Nippon Juishikai Zasshi 1993;46:487-491.
47. Andrew SE, Brooks DE, Smith PJ, et al. Equine ulcerative keratomycosis: visual outcome and ocular survival in 39 cases (1987-1996). Equine Vet J 1998;30:109-116.
48. Schmidt GM. Problem oriented ophthalmology. Part 4. Corneal ulceration. Mod Vet Pract 1977;58:25-28.
49. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-2154.
50. Galis ZS, Asanuma K, Godin D, et al. N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy? Circulation 1998;97:2445-2453.
51. Thermes F, Molon-Noblot S, Grove J. Effects of acetylcysteine on rabbit conjunctival and corneal surfaces. Invest Ophthalmol Vis Sci 1991;32:2958-2964.
52. Petroutsos G, Guimaraes R, Giraud JP, et al. Effect of acetylcysteine (Mucomyst) on epithelial wound healing. Ophthalmic Res 1982; 14:241-248.
53. Twining SS, Fukuchi T, Yue BY, et al. Alpha 2-macroglobulin is present in and synthesized by the cornea. Invest Ophthalmol Vis Sci 1994;35:3226-3233.
54. La Lau C. Continuous lavage in (chemical) corneal lesions. Doc Ophthalmol 1979;46:215-218.
55. Twining SS, Fukuchi T, Yue BY, et al. Corneal synthesis of alpha 1-proteinase inhibitor (alpha 1-antitrypsin). Invest Ophthalmol Vis Sci 1994;35:458-462.
56. Liu Z, Zhou X, Shapiro SD, et al. The serpin alpha 1-proteinase inhibitor is a critical substrate for gelatinase B/MMP9 in vivo. Cell 2000;102:647-655.
57. Burns FR, Gray RD, Paterson CA. Inhibition of alkali-induced corneal ulceration and perforation by a thiol peptide. Invest Ophthalmol Vis Sci 1990;31:107-114.
58. Burns FR, Paterson CA, Gray RD, et al. Inhibition of Pseudomonas aeruginosa elastase and Pseudomonas keratitis using a thiol-based peptide. Antimicrob Agents Chemother 1990;34:2065-2069.
59. Hao JL, Nagano T, Nakamura M, et al. Galardin inhibits collagen degradation by rabbit keratocytes by inhibiting the activation of pro-matrix metalloproteinases. Exp Eye Res 1999;68:565-572.
60. Hao JL, Nagano T, Nakamura M, et al. Effect of Galardin on collagen degradation by Pseudomonas aeruginosa. Exp Eye Res 1999; 69:595-601.